Vireo Growth (VREOF) Tax Rate Growth (1y) (2021 - 2026)
Vireo Growth (VREOF) Tax Rate Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,030.00 |
| Dec 31, 2025 | -14,219.00 |
| Sep 30, 2025 | -920.00 |
| Jun 30, 2025 | 14,448.00 |
| Mar 31, 2025 | 10,718.00 |
| Dec 31, 2024 | -7,501.00 |
| Sep 30, 2024 | 13,371.00 |
| Jun 30, 2024 | -16,382.00 |
| Mar 31, 2024 | -11,702.00 |
| Dec 31, 2023 | 6,342.00 |
| Sep 30, 2023 | -20,456.00 |
| Jun 30, 2023 | -1,003.00 |
| Mar 31, 2023 | -1,715.00 |
| Dec 31, 2022 | -704.00 |
| Sep 30, 2022 | -1,460.00 |
| Jun 30, 2022 | -428.00 |
| Mar 31, 2022 | 2,383.00 |
| Dec 31, 2021 | 101,431.00 |
| Sep 30, 2021 | -4,997.00 |
| Jun 30, 2021 | -1,230.00 |